3. Discussion Both our patients had micro-prolactinomas, for which they were prescribed
cabergoline, and subsequently, developed psychotic and mood symptoms, which were …

DISCUSSION Psychosis is a rare side effect of DA. Cabergoline's potential to cause or
exacerbate psychosis has been reported in few cases when treating prolactinomas and is …

Cabergoline, a dopamine agonist agent, is commonly used in the treatment of
hyperprolactinemia, Parkinson's disease, restless leg syndrome, and antipsychotic-induced …

Cabergoline is a potent dopamine receptor agonist on D2 receptor and primarily used for
the treatment of disorders with hyperprolactinemia, as a result of idiopathic effect or …

To the Editor: Dopamine agonists bromocriptine and cabergoline are used in the medical
treatment of prolactinomas. 1 Emergence of psychotic symptoms is a more established …

Up to date, only a small evidence of psychosis induced by cabergoline is available in
literature. Herein, the case of a 34-year-old bipolar patient treated with cabergoline has …

Atypical antipsychotic-induced hyperprolactinemia can cause important clinical symptoms,
particularly in young women and also in men, such as impotence, loss of libido …

Psychosis resulting from bromocriptine administration in patients with a prolactinoma
represents a difficult therapeutic challenge. Discontinuation of bromocriptine is usually …

Cabergoline is an orally administered synthetic dopamine agonist that is used for the
treatment of hyperprolactinemia, Parkinson's disease and antipsychotic-induced prolactin …

Hyperprolactinemia has been reported to be associated with multiple symptoms of
depression as well as decreased libido, galactorrhea, and menstrual irregularities.[1-4] It is …